Literature DB >> 23518352

SnapShot: pancreatic cancer.

Haiyong Han1, Daniel D Von Hoff.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23518352      PMCID： PMC3638898          DOI： 10.1016/j.ccr.2013.03.008

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  10 in total

1.  FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Authors:  Thierry Conroy; Françoise Desseigne; Marc Ychou; Olivier Bouché; Rosine Guimbaud; Yves Bécouarn; Antoine Adenis; Jean-Luc Raoul; Sophie Gourgou-Bourgade; Christelle de la Fouchardière; Jaafar Bennouna; Jean-Baptiste Bachet; Faiza Khemissa-Akouz; Denis Péré-Vergé; Catherine Delbaldo; Eric Assenat; Bruno Chauffert; Pierre Michel; Christine Montoto-Grillot; Michel Ducreux
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

2.  Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Authors:  H A Burris; M J Moore; J Andersen; M R Green; M L Rothenberg; M R Modiano; M C Cripps; R K Portenoy; A M Storniolo; P Tarassoff; R Nelson; F A Dorr; C D Stephens; D D Von Hoff
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

3.  Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors.

Authors:  Triantafyllos Stylianopoulos; John D Martin; Vikash P Chauhan; Saloni R Jain; Benjamin Diop-Frimpong; Nabeel Bardeesy; Barbara L Smith; Cristina R Ferrone; Francis J Hornicek; Yves Boucher; Lance L Munn; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-29       Impact factor: 11.205

Review 4.  Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing.

Authors:  Christine A Iacobuzio-Donahue; Victor E Velculescu; Christopher L Wolfgang; Ralph H Hruban
Journal:  Clin Cancer Res       Date:  2012-08-15       Impact factor: 12.531

Review 5.  The pancreas cancer microenvironment.

Authors:  Christine Feig; Aarthi Gopinathan; Albrecht Neesse; Derek S Chan; Natalie Cook; David A Tuveson
Journal:  Clin Cancer Res       Date:  2012-08-15       Impact factor: 12.531

6.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

7.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.

Authors:  Sunil R Hingorani; Lifu Wang; Asha S Multani; Chelsea Combs; Therese B Deramaudt; Ralph H Hruban; Anil K Rustgi; Sandy Chang; David A Tuveson
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

8.  A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development.

Authors:  Antonio Jimeno; Georg Feldmann; Ana Suárez-Gauthier; Zeshaan Rasheed; Anna Solomon; Gang-Ming Zou; Belen Rubio-Viqueira; Elena García-García; Fernando López-Ríos; William Matsui; Anirban Maitra; Manuel Hidalgo
Journal:  Mol Cancer Ther       Date:  2009-01-27       Impact factor: 6.261

9.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

10.  Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.

Authors:  Malcolm J Moore; David Goldstein; John Hamm; Arie Figer; Joel R Hecht; Steven Gallinger; Heather J Au; Pawel Murawa; David Walde; Robert A Wolff; Daniel Campos; Robert Lim; Keyue Ding; Gary Clark; Theodora Voskoglou-Nomikos; Mieke Ptasynski; Wendy Parulekar
Journal:  J Clin Oncol       Date:  2007-04-23       Impact factor: 44.544
  10 in total
  22 in total

1.  MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.

Authors:  Weihua Chang; Menggang Liu; Jianhua Xu; Hangwei Fu; Bo Zhou; Tao Yuan; Ping Chen
Journal:  Tumour Biol       Date:  2016-09-16

2.  Augmented TGFβ receptor signaling induces apoptosis of pancreatic carcinoma cells.

Authors:  Chenggang Li; Zhiming Zhao; Zhipeng Zhou; Rong Liu
Journal:  Tumour Biol       Date:  2014-12-05

3.  Hyaluronidase-Expressing Salmonella Effectively Targets Tumor-Associated Hyaluronic Acid in Pancreatic Ductal Adenocarcinoma.

Authors:  Nancy D Ebelt; Edith Zuniga; Kevin B Passi; Lukas J Sobocinski; Edwin R Manuel
Journal:  Mol Cancer Ther       Date:  2019-11-06       Impact factor: 6.261

4.  Interplay of miR-21 and FoxO1 modulates growth of pancreatic ductal adenocarcinoma.

Authors:  Weifeng Song; Lei Wang; Liwei Wang; Qi Li
Journal:  Tumour Biol       Date:  2015-01-27

5.  Lung metastasis of pancreatic carcinoma is regulated by TGFβ signaling.

Authors:  Liqiang Song; Ping Wang; Yu Tian; De Chang; Kailong Li; Yongna Fan; Jing Shen; Hongzhen Du; Ruifang Mi; Xiaoxia Bian; Xianchao Tang
Journal:  Tumour Biol       Date:  2014-11-20

6.  Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors.

Authors:  Edwin R Manuel; Jeremy Chen; Massimo D'Apuzzo; Melanie G Lampa; Teodora I Kaltcheva; Curtis B Thompson; Thomas Ludwig; Vincent Chung; Don J Diamond
Journal:  Cancer Immunol Res       Date:  2015-07-01       Impact factor: 11.151

7.  TGFβ signaling in pancreatic ductal adenocarcinoma.

Authors:  Hui Zhang; Chengli Liu; Yalin Kong; Hui Huang; Cheng Wang; Hongyi Zhang
Journal:  Tumour Biol       Date:  2014-10-31

8.  Human pancreatic cancer progression: an anarchy among CCN-siblings.

Authors:  Sushanta K Banerjee; Gargi Maity; Inamul Haque; Arnab Ghosh; Sandipto Sarkar; Vijayalaxmi Gupta; Donald R Campbell; Daniel Von Hoff; Snigdha Banerjee
Journal:  J Cell Commun Signal       Date:  2016-08-19       Impact factor: 5.782

9.  Cyr61 promotes growth of pancreatic carcinoma via nuclear exclusion of p27.

Authors:  Weidong Shi; Jianhua Yin; Zhen Chen; Hao Chen; Luming Liu; Zhiqiang Meng
Journal:  Tumour Biol       Date:  2014-08-08

Review 10.  Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease.

Authors:  Christopher Gromisch; Motaz Qadan; Mariana Albuquerque Machado; Kebin Liu; Yolonda Colson; Mark W Grinstaff
Journal:  Cancer Res       Date:  2020-03-27       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.